IC
CDAK

Ikarian Capital’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

Ikarian Capital’s Portfolio CDAK Stock Details CDAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-52,177
Closed -$328K – 222
2022
Q1 		$328K Buy
52,177
+2,497
+5% +$15.7K 0.04% 152
2021
Q4 		$554K Sell
49,680
-70,215
-59% -$973K 0.08% 123
2021
Q3 		$1.96M Buy
+119,895
New +$2.14M 0.14% 126

Other funds holding CDAK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Ikarian Capital's CDAK Position: Q2 2022 in Review

Ikarian Capital sold out of Codiak BioSciences, Inc. Common Stock (CDAK) in Q2 2022, closing a stake of 52,177 shares — an estimated $328K sold.

Ikarian Capital first reported a position in CDAK in Q3 2021 and held it in 3 quarters. The position peaked at $1.96M in Q3 2021. 49 funds tracked by Wall St. Rank hold CDAK as of Q2 2022.

  • Ikarian Capital reported no remaining Codiak BioSciences, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Ikarian Capital sold 52,177 Codiak BioSciences, Inc. Common Stock shares in Q2 2022, an estimated $328K.
  • Ikarian Capital first reported a position in Codiak BioSciences, Inc. Common Stock in Q3 2021 and held it in 3 quarters.
  • Ikarian Capital's Codiak BioSciences, Inc. Common Stock position peaked at $1.96M in Q3 2021.
  • 49 funds tracked by Wall St. Rank held Codiak BioSciences, Inc. Common Stock as of Q2 2022.

Based on Ikarian Capital's 13F filing for Q2 2022, filed 12 Aug 2022.